Continuously tracking blood pressure without an inflating cuff has moved from research lab to consumer wrist in the past two years. In 2026 the technology is real, commercially available in some markets, and replicable by makers on breakout boards — but accuracy limits, regulatory hurdles, and calibration dependencies mean understanding the engineering matters before trusting the numbers.
This article synthesizes the current state of cuffless BP monitoring: how it works, which consumer devices are shipping, what the regulatory picture looks like, and how makers can prototype with off-the-shelf sensor ICs.
How Cuffless Blood Pressure Monitoring Works
The traditional arm cuff inflates to temporarily occlude arterial flow, then measures oscillations as pressure releases. Continuous monitoring with a cuff is impractical: it is uncomfortable, requires repeated inflation, and disrupts sleep. Cuffless designs sidestep inflation by reading signals passively from the skin.
Three Signal Pathways
Photoplethysmography (PPG). An LED — typically red, infrared, or green — shines into the skin surface. A photodetector measures how much light returns, modulated by the volume of blood in the capillary bed with each heartbeat. The resulting waveform encodes the shape of the arterial pressure pulse: its rise time, peak, dicrotic notch, and decay slope all correlate with arterial stiffness and, by extension, blood pressure. Wrist-worn devices from Samsung and Aktiia primarily use this approach.
Pulse Transit Time (PTT). The heart's contraction launches a pressure wave that travels from the aorta to the periphery. PTT is the time delay between an ECG R-peak (the electrical trigger of ventricular contraction) and the corresponding PPG pulse foot at a distal site such as the wrist. Because stiffer, higher-pressure arteries conduct the wave faster, shorter PTT correlates with higher blood pressure. PTT requires two sensor locations: an ECG electrode near the heart and a PPG sensor at the extremity. The Maxim MAX86150 IC integrates both modalities in a single package, enabling single-device PTT prototyping.
Multi-sensor fusion. Leading 2026 implementations layer PPG, ECG, an inertial measurement unit (IMU), and in some cases skin temperature. The IMU is critical: motion artifacts contaminate PPG signals severely, and accelerometer data allows real-time adaptive filtering to separate the cardiac waveform from movement noise. AI models trained on large paired datasets then map the cleaned feature set to pressure estimates.
The Calibration Dependency
Per FDA guidance on non-invasive blood pressure monitoring devices, no currently cleared cuffless consumer wearable measures absolute blood pressure without an initial calibration against a traditional cuff. Calibration personalizes the algorithm's model to an individual's arterial compliance — a property that drifts with stress, hydration, medication, and aging, explaining why periodic recalibration is a common product requirement rather than a one-time setup step.
The Regulatory Landscape in 2026
The FDA distinguishes between devices that track trends and devices that measure clinical blood pressure. This distinction drives product design decisions across the industry.
| Regulatory status | Example | BP output | Calibration | Accuracy standard |
|---|---|---|---|---|
| FDA-cleared (oscillometric wrist cuff) | Omron HeartGuide | Numeric systolic/diastolic | None | ISO 81060-2 |
| CE-certified, not FDA-cleared | Aktiia bracelet | Numeric systolic/diastolic | Initial cuff reading | ISO 81060-2 Grade B |
| Wellness feature (no clearance claimed) | Apple Watch (watchOS 11+) | Trend classification only | None | Internal validation |
| Market-limited (not US FDA) | Samsung Galaxy Watch 7 Health Monitor | Numeric (in-app) | Monthly cuff reading | Samsung internal |
The American Heart Association, in its published guidance on wearable cardiovascular devices, notes that cuffless monitors show promise for population-level research and patient engagement, but cautions that accuracy varies substantially across skin tones, BMI ranges, and activity levels, and that devices should not replace confirmed clinical readings for treatment decisions.
For the maker community this regulatory context is directly relevant: a wearable built on a PPG breakout board is a research instrument. Bringing it to FDA clearance requires clinical trials against a predicate device — a multi-year, multi-million-dollar process well outside a hobbyist scope.
Leading Consumer Devices Worth Understanding
Samsung Galaxy Watch 7 and Galaxy Watch Ultra
Samsung's Galaxy Watch series uses a dedicated Bio-Active Sensor with multiple optical LED wavelengths and a single-lead ECG electrode, enabling a PTT-adjacent computation. The Samsung Health Monitor app delivers the BP feature. Per Samsung's published technical documentation, the system builds a personalized model anchored by mandatory monthly cuff calibration. As of mid-2026 the BP feature remains unavailable in the United States, where Samsung has not received FDA clearance; it operates in South Korea and a subset of other markets.
Aktiia Bracelet
Aktiia is a Swiss medical-technology company whose optical bracelet earned CE certification under the EU's Medical Device Regulation (MDR), specifically validated against ISO 81060-2 Grade B criteria — a mean error within 5 mmHg and standard deviation within 8 mmHg versus a reference device in the studied population. The bracelet takes readings approximately every 30 minutes during wear, uploads via BLE to a companion app, and generates daytime versus nighttime breakdown views. Aktiia's peer-reviewed clinical publications highlight nocturnal BP capture as a key differentiator: nighttime patterns are otherwise accessible only via 24-hour ambulatory BP monitoring (ABPM), a clinical procedure typically performed in a sleep lab.
Apple Watch (watchOS 11+)
Apple announced blood pressure trend detection for watchOS 11, available on Apple Watch Series 10 and Ultra 2. Per Apple's WWDC 2024 announcement, the feature does not report numeric blood pressure values — it classifies patterns as "consistent with elevated" or "consistent with normal," generating a conversation prompt for users to discuss with their clinician. No calibration is required. Apple frames this deliberately as a wellness feature, avoiding the 510(k) or de novo FDA pathway that numeric output would trigger. The trade-off is zero setup friction for users against reduced clinical actionability.
Withings ScanWatch 2
The ScanWatch 2 integrates FDA-cleared AFib detection via PPG, continuous SpO₂, ECG recording, and sleep tracking. Withings has not shipped a cuffless BP measurement feature for the ScanWatch 2 as of mid-2026, though the hardware is capable. The company has communicated blood pressure monitoring as a planned software addition pending regulatory pathway completion.
DIY and Maker Integration
For the maker community, practical entry points exist via optical PPG sensor breakout boards paired with microcontrollers or single-board computers.
Maxim MAX30102 and MAX86150
The MAX30102 integrates a red and infrared LED pair with a photodetector in a compact package. Available as a breakout board from Adafruit and SparkFun, it communicates over I²C and is compatible with Arduino, ESP32, and Raspberry Pi. Per Adafruit's published product documentation, the chip operates in the sub-1 mA range during active sampling at typical LED brightness settings, with sleep current well under 20 µA — practical for duty-cycled battery wearables.
The MAX86150, a successor IC, adds a single-lead ECG front-end — enabling PTT computation from a single package if paired with a contact ECG electrode. For cuffless BP research prototypes, this dual-modality chip offers the most signal richness available in a maker-accessible form factor.
A Reference Prototype Stack
A minimal research-grade wearable build for PTT-based BP investigation:
| Layer | Component | Purpose |
|---|---|---|
| Optical + ECG sensor | MAX86150 breakout | PPG waveform + R-peak timing |
| Microcontroller | ESP32-S3 | Signal acquisition, DSP, BLE |
| Motion compensation | MPU-6050 (6-axis IMU) | Artifact rejection |
| Power | 300–500 mAh LiPo | Wearable battery |
| Host processing | Raspberry Pi / PC | PTT extraction, model inference |
| Software | Python (scipy, neurokit2) | Peak detection, feature extraction |
Open-source repositories on GitHub host PPG and ECG peak-detection pipelines in Python and C, including Pan-Tompkins implementations for ECG R-peak detection and first-derivative threshold methods for PPG foot-point detection — the two signals whose inter-peak delay defines PTT.
Accuracy Expectations
Published literature in IEEE Transactions on Biomedical Engineering and Physiological Measurement consistently documents mean absolute errors of 5–10 mmHg for systolic and 4–8 mmHg for diastolic from PPG-only algorithms under controlled laboratory conditions, degrading under motion, variable ambient temperature, and diverse skin tones. PTT-based approaches reduce these errors in controlled studies but require rigorous personal calibration. Makers should treat prototype builds as signal-processing research tools, not clinical instruments, and calibrate against a validated cuff-based device for any physiological interpretation.
Nighttime Monitoring: Where Cuffless Excels
One clinically meaningful advantage cuffless wearables hold over intermittent cuff monitors is overnight BP capture. Nighttime blood pressure dipping — the normal 10–20% reduction during sleep — is an independent cardiovascular risk marker: non-dippers (people whose BP does not fall overnight) face elevated risk of cardiac and renal events. Traditional cuff monitors that inflate on an hourly schedule disturb sleep architecture; wrist-worn optical devices running duty-cycled sensors can sample every 20–30 minutes without waking the wearer.
Aktiia's published clinical work specifically highlights nocturnal capture as a primary use case. Community reports from users in South Korea and EU markets where Samsung and Aktiia features are live similarly identify overnight trend views as highly used outputs — data that was previously practical only via in-clinic 24-hour ABPM.
Comparing Methods at a Glance
| Method | Sensor inputs | Calibration | Clearance pathway | Practical for makers? |
|---|---|---|---|---|
| Oscillometric wrist cuff | Pneumatic | None | FDA 510(k) | No (requires cuff hardware) |
| PPG wrist (single-point) | Optical only | Periodic | Trend claims only | Yes — MAX30102 / MAX86150 |
| PTT (PPG + ECG) | Optical + electrical | Initial | More defensible data | Yes — MAX86150 |
| Multi-modal AI fusion | PPG + ECG + IMU | Initial | Commercial approach | Advanced prototype |
Explore More at SpecPicks
SpecPicks covers display hardware alongside maker and health topics. If you're building a Raspberry Pi health dashboard or a dedicated wearable data station and need a display, these roundups may help:
- Best 4K Monitor for PS5 and PC Under $500: KOORUI QD-Mini LED vs Samsung Odyssey
- Pro-Level 180Hz 1440p Gaming Monitor for $159
- Bigme Color E-Ink Monitor: 60 FPS and 4096 Colors Explained — low-power e-ink panels suit always-on health data displays
- KOORUI 4K QD-Mini LED vs Samsung Odyssey 4K
- Best 27-Inch 4K Gaming Monitor: KOORUI QD-Mini LED vs Samsung Odyssey
- Samsung Odyssey 4K vs KOORUI QD-Mini LED: Best 4K Gaming Monitor?
- Is an RTX 3060 Enough for 4K Gaming? Pairing It With a Budget 4K Monitor
- Prime Day 2026: Gaming Monitor and Logitech Peripheral Deals to Watch
Citations and sources
- https://www.fda.gov/medical-devices/digital-health-center-excellence/blood-pressure-monitoring-devices
- https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home
- https://www.aktiia.com/en-us/technology
- https://news.samsung.com/global/samsung-health-monitor-app-blood-pressure-measurement
- https://www.apple.com/newsroom/2024/06/watchos-11-makes-apple-watch-an-even-more-powerful-health-partner/
- https://www.withings.com/us/en/scanwatch-2
- https://learn.adafruit.com/adafruit-max30102-breakout
- https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10
This piece is editorial synthesis based on publicly available information. No independent first-party benchmarking is reported.